Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HealthSonix is a medical technology company specializing in the development and delivery of non-invasive acoustic wave therapy for urological and orthopedic conditions. The company primarily utilizes Low-Intensity Extracorporeal Shockwave Therapy (Li-ESWT) to treat indications such as erectile dysfunction, Peyronie's disease, and chronic pelvic pain syndrome. Their technology is designed to stimulate natural healing processes, including angiogenesis and improved blood circulation, providing an alternative to surgical or pharmaceutical interventions. HealthSonix operates as a specialized provider within the urology space, often collaborating with large physician groups to integrate their therapeutic protocols into clinical practice. The company's platform emphasizes patient safety and clinical efficacy through standardized treatment regimens.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HealthSonix.